Dare Bioscience, Inc. Increase (Decrease) in Restricted Cash
Dare Bioscience, Inc. (DARE) reported Increase (Decrease) in Restricted Cash of -$230.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2017-08-14
- Dare Bioscience, Inc. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in restricted cash for the quarter ending 2016-09-30 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in restricted cash for the quarter ending 2016-06-30 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in restricted cash for the quarter ending 2016-03-31 was -$117.00K.
- Dare Bioscience, Inc. increase (decrease) in restricted cash for fiscal 2016 was -$117.00K, a 150.87% decline from fiscal 2015.
- Dare Bioscience, Inc. increase (decrease) in restricted cash for fiscal 2015 was $230.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$230.00K 10-Q · filed 2017-08-14 | |||
| 2016-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | $0.00 derived: sum of 2 quarters · filed 2017-06-13 | $0.00 derived: sum of 3 quarters · filed 2017-08-14 | -$117.00K 10-K/A · filed 2017-06-13 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2017-08-14 | -$117.00K 10-Q · filed 2016-11-03 | -$117.00K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$117.00K 10-Q · filed 2017-08-14 | -$117.00K derived: sum of 3 quarters · filed 2017-08-14 | -$117.00K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$117.00K 10-Q · filed 2017-05-12 | -$117.00K derived: sum of 2 quarters · filed 2017-06-13 | -$117.00K derived: sum of 3 quarters · filed 2017-06-13 | |
| 2015-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | $0.00 derived: sum of 2 quarters · filed 2017-06-13 | $230.00K 10-K/A · filed 2017-06-13 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $230.00K 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $230.00K 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |